News
New publication on MET alterations informing on therapy sensitivity
MET F/SVs but not genomic amplification, were highly enriched in the secondary glioblastomas (sGBM) and marked worse prognosis.
“All THIS MESS: checking validity in clinical studies.”
Data Prevalence is defining co-founder in statistics. Thanks for your visit Dr. Klimova from NCT partner site Dresden.
Invited talk
Invited talk at NOA Annual Meeting in Kopfklinik University Medical Center Heidelberg. Interesting to learn about the Alcatraz concept of cancer therapy.
Invited talk
Invited talk Nano2Clinic Final conference @ La Sapienza, Rome. Great progress towards position paper on innovation for future drug development and new COST Action establishment.
Great organization by Sabrina Pricl, University of Trieste.
Inauguration Rector H2
Inauguration celebration for Manuela Schwartz. Interesting gathering of representatives from research, funding organization, religion, politics and art! Best of success and luck with decisions in your new position!